International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Oct 2024, Vol 12, Issue 4

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Case Report
Non-endometrioid Synchronized Endometrial and Ovarian Carcinoma: Report of Two Rare Cases
Soheila Aminimoghaddam¹, Elham Saffarieh², Pegah Kamkarfar³, Mahsa Kiani³, Parinaz Hamednasimi³
¹Department of Obstetrics and Gynecology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran ²Abnormal Uterine Bleeding Center of Semnan University of Medical Sciences, Semnan, Iran ³Endometriosis Research Centers of Iran University of Medical Sciences, Tehran, Iran
IJWHR 2024; 12: 190-194 DOI: 10.15296/ijwhr.2023.8010 Viewed : 955 times Downloaded : 891 times. Keywords : Papillary serous carcinoma, Clear cell carcinoma, synchronized endometrial, Ovarian cancer
Full Text(PDF) \| Related Articles
Abstract

Objectives: Synchronized endometrial and ovarian cancer (SEOC) is a condition in which there is both primary endometrial and primary ovarian cancer at the same time in a patient. These tumors have a better prognosis than metastatic ones. Most of them are diagnosed in the early stages and are low-grade tumors. So differentiation of this kind of rare tumor from others is essential. No adjuvant chemotherapy seems to be reasonable in cases with low-grade tumors both in endometrioid and non-endometrioid types. High-grades tumors have been described less, but, in some studies, genetic mutations were found in these tumors, which have been the basis of targeted therapy after surgery. Case Presentation: In this report, two rare non-endometrioid types of SEOC cases are discussed. The first case is a low-grade papillary serous carcinoma of the ovary and uterus endometrium. In contrast, the second case is a clear cell carcinoma of the ovary and endometrioid adenocarcinoma of the uterus. We also review the literature in this field. Conclusion: We conclude that in these cases, chemotherapy with routine regimens does not seem to be helpful in early stages with low-grade tumors. Also, in high-grade tumors, targeted therapy may be more effective than adjuvant chemotherapy.